BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24014128)

  • 1. The functional Aquaporin 1 -783G/C-polymorphism is associated with survival in patients with glioblastoma multiforme.
    El Hindy N; Rump K; Lambertz N; Zhu Y; Frey UH; Bankfalvi A; Siffert W; Sure U; Peters J; Adamzik M; Sandalcioglu IE
    J Surg Oncol; 2013 Dec; 108(7):492-8. PubMed ID: 24014128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.
    El Hindy N; Bachmann HS; Lambertz N; Adamzik M; Nückel H; Worm K; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
    J Neurosurg; 2011 Jun; 114(6):1631-9. PubMed ID: 21250804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional polymorphism in the pre‑miR‑146a gene influences the prognosis of glioblastoma multiforme by interfering with the balance between Notch1 and Notch2.
    Liu R; Li W; Wu C
    Mol Med Rep; 2015 Oct; 12(4):5475-81. PubMed ID: 26165719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.
    Adamzik M; Frey UH; Bitzer K; Jakob H; Baba HA; Schmieder RE; Schneider MP; Heusch G; Peters J; Siffert W
    Basic Res Cardiol; 2008 Nov; 103(6):598-610. PubMed ID: 18846354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aquaporin-1 gene polymorphism on water retention in liver cirrhosis.
    Fábrega E; Berja A; García-Unzueta MT; Guerra-Ruiz A; Cobo M; López M; Bolado-Carrancio A; Amado JA; Rodríguez-Rey JC; Pons-Romero F
    Scand J Gastroenterol; 2011 Oct; 46(10):1267-74. PubMed ID: 21793635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
    Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W
    Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type-1 domain-containing 7A in glioblastoma.
    Oishi M; Munesue S; Harashima A; Nakada M; Yamamoto Y; Hayashi Y
    Cancer Med; 2020 Jun; 9(11):3904-3917. PubMed ID: 32253832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma.
    Vauleon E; Auger N; Benouaich-Amiel A; Laigle-Donadey F; Kaloshi G; Lejeune J; Delattre JY; Thillet J; Sanson M
    Cancer Genet Cytogenet; 2007 Jan; 172(1):33-7. PubMed ID: 17175377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.
    Wang L; Wei Q; Wang LE; Aldape KD; Cao Y; Okcu MF; Hess KR; El-Zein R; Gilbert MR; Woo SY; Prabhu SS; Fuller GN; Bondy ML
    J Clin Oncol; 2006 Apr; 24(10):1627-32. PubMed ID: 16575014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the GNAS1 T393C polymorphism in patients with glioblastoma multiforme.
    El Hindy N; Lambertz N; Bachmann HS; Frey UH; Adamzik M; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
    J Clin Neurosci; 2011 Nov; 18(11):1495-9. PubMed ID: 21924916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.
    Lakomy R; Sana J; Hankeova S; Fadrus P; Kren L; Lzicarova E; Svoboda M; Dolezelova H; Smrcka M; Vyzula R; Michalek J; Hajduch M; Slaby O
    Cancer Sci; 2011 Dec; 102(12):2186-90. PubMed ID: 21895872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.
    Pei C; Chen H; Jia X; Yan L; Zou Y; Jiang C; Jin H; Kang C; Jiang T; Ren H
    Int J Neurosci; 2013 Feb; 123(2):114-20. PubMed ID: 23057844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.
    Kase M; Vardja M; Lipping A; Asser T; Jaal J
    Radiother Oncol; 2011 Oct; 101(1):127-31. PubMed ID: 21775006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
    Amoureux MC; Coulibaly B; Chinot O; Loundou A; Metellus P; Rougon G; Figarella-Branger D
    BMC Cancer; 2010 Mar; 10():91. PubMed ID: 20219118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.